Clinical practice guideline for Sjögren’s syndrome 2017

Takayuki Sumida, Naoto Azuma, Masafumi Moriyama, Hiroyuki Takahashi, Hiromitsu Asashima, Fumika Honda, Saori Abe, Yuko Ono, Tomoya Hirota, Shintaro Hirata, Yoshiya Tanaka, Toshimasa Shimizu, Hideki Nakamura, Atsushi Kawakami, Hajime Sano, Yoko Ogawa, Kazuo Tsubota, Koufuchi Ryo, Ichiro Saito, Akihiko TanakaSeiji Nakamura, Etsuko Takamura, Masao Tanaka, Katsuya Suzuki, Tsutomu Takeuchi, Noriyuki Yamakawa, Tsuneyo Mimori, Akiko Ohta, Susumu Nishiyama, Toshio Yoshihara, Yasunori Suzuki, Mitsuhiro Kawano, Minako Tomiita, Hiroto Tsuboi

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Objectives: The objective of this study is to develop clinical practice guideline (CPG) for Sjögren’s syndrome (SS) based on recently available clinical and therapeutic evidences. Methods: The CPG committee for SS was organized by the Research Team for Autoimmune Diseases, Research Program for Intractable Disease of the Ministry of Health, Labor and Welfare (MHLW), Japan. The committee completed a systematic review of evidences for several clinical questions and developed CPG for SS 2017 according to the procedure proposed by the Medical Information Network Distribution Service (Minds). The recommendations and their strength were checked by the modified Delphi method. The CPG for SS 2017 has been officially approved by both Japan College of Rheumatology and the Japanese Society for SS. Results: The CPG committee set 38 clinical questions for clinical symptoms, signs, treatment, and management of SS in pediatric, adult and pregnant patients, using the PICO (P: patients, problem, population, I: interventions, C: comparisons, controls, comparators, O: outcomes) format. A summary of evidence, development of recommendation, recommendation, and strength for these 38 clinical questions are presented in the CPG. Conclusion: The CPG for SS 2017 should contribute to improvement and standardization of diagnosis and treatment of SS.

Original languageEnglish
Pages (from-to)383-408
Number of pages26
JournalModern Rheumatology
Volume28
Issue number3
DOIs
Publication statusPublished - May 4 2018

Fingerprint

Practice Guidelines
Japan
Information Services
Information Dissemination
Rheumatology
Research
Autoimmune Diseases
Signs and Symptoms
Therapeutics
Pediatrics
Health
Population

All Science Journal Classification (ASJC) codes

  • Rheumatology

Cite this

Sumida, T., Azuma, N., Moriyama, M., Takahashi, H., Asashima, H., Honda, F., ... Tsuboi, H. (2018). Clinical practice guideline for Sjögren’s syndrome 2017. Modern Rheumatology, 28(3), 383-408. https://doi.org/10.1080/14397595.2018.1438093

Clinical practice guideline for Sjögren’s syndrome 2017. / Sumida, Takayuki; Azuma, Naoto; Moriyama, Masafumi; Takahashi, Hiroyuki; Asashima, Hiromitsu; Honda, Fumika; Abe, Saori; Ono, Yuko; Hirota, Tomoya; Hirata, Shintaro; Tanaka, Yoshiya; Shimizu, Toshimasa; Nakamura, Hideki; Kawakami, Atsushi; Sano, Hajime; Ogawa, Yoko; Tsubota, Kazuo; Ryo, Koufuchi; Saito, Ichiro; Tanaka, Akihiko; Nakamura, Seiji; Takamura, Etsuko; Tanaka, Masao; Suzuki, Katsuya; Takeuchi, Tsutomu; Yamakawa, Noriyuki; Mimori, Tsuneyo; Ohta, Akiko; Nishiyama, Susumu; Yoshihara, Toshio; Suzuki, Yasunori; Kawano, Mitsuhiro; Tomiita, Minako; Tsuboi, Hiroto.

In: Modern Rheumatology, Vol. 28, No. 3, 04.05.2018, p. 383-408.

Research output: Contribution to journalReview article

Sumida, T, Azuma, N, Moriyama, M, Takahashi, H, Asashima, H, Honda, F, Abe, S, Ono, Y, Hirota, T, Hirata, S, Tanaka, Y, Shimizu, T, Nakamura, H, Kawakami, A, Sano, H, Ogawa, Y, Tsubota, K, Ryo, K, Saito, I, Tanaka, A, Nakamura, S, Takamura, E, Tanaka, M, Suzuki, K, Takeuchi, T, Yamakawa, N, Mimori, T, Ohta, A, Nishiyama, S, Yoshihara, T, Suzuki, Y, Kawano, M, Tomiita, M & Tsuboi, H 2018, 'Clinical practice guideline for Sjögren’s syndrome 2017', Modern Rheumatology, vol. 28, no. 3, pp. 383-408. https://doi.org/10.1080/14397595.2018.1438093
Sumida, Takayuki ; Azuma, Naoto ; Moriyama, Masafumi ; Takahashi, Hiroyuki ; Asashima, Hiromitsu ; Honda, Fumika ; Abe, Saori ; Ono, Yuko ; Hirota, Tomoya ; Hirata, Shintaro ; Tanaka, Yoshiya ; Shimizu, Toshimasa ; Nakamura, Hideki ; Kawakami, Atsushi ; Sano, Hajime ; Ogawa, Yoko ; Tsubota, Kazuo ; Ryo, Koufuchi ; Saito, Ichiro ; Tanaka, Akihiko ; Nakamura, Seiji ; Takamura, Etsuko ; Tanaka, Masao ; Suzuki, Katsuya ; Takeuchi, Tsutomu ; Yamakawa, Noriyuki ; Mimori, Tsuneyo ; Ohta, Akiko ; Nishiyama, Susumu ; Yoshihara, Toshio ; Suzuki, Yasunori ; Kawano, Mitsuhiro ; Tomiita, Minako ; Tsuboi, Hiroto. / Clinical practice guideline for Sjögren’s syndrome 2017. In: Modern Rheumatology. 2018 ; Vol. 28, No. 3. pp. 383-408.
@article{1e4ec053d968419b94828e1caf2533c0,
title = "Clinical practice guideline for Sj{\"o}gren’s syndrome 2017",
abstract = "Objectives: The objective of this study is to develop clinical practice guideline (CPG) for Sj{\"o}gren’s syndrome (SS) based on recently available clinical and therapeutic evidences. Methods: The CPG committee for SS was organized by the Research Team for Autoimmune Diseases, Research Program for Intractable Disease of the Ministry of Health, Labor and Welfare (MHLW), Japan. The committee completed a systematic review of evidences for several clinical questions and developed CPG for SS 2017 according to the procedure proposed by the Medical Information Network Distribution Service (Minds). The recommendations and their strength were checked by the modified Delphi method. The CPG for SS 2017 has been officially approved by both Japan College of Rheumatology and the Japanese Society for SS. Results: The CPG committee set 38 clinical questions for clinical symptoms, signs, treatment, and management of SS in pediatric, adult and pregnant patients, using the PICO (P: patients, problem, population, I: interventions, C: comparisons, controls, comparators, O: outcomes) format. A summary of evidence, development of recommendation, recommendation, and strength for these 38 clinical questions are presented in the CPG. Conclusion: The CPG for SS 2017 should contribute to improvement and standardization of diagnosis and treatment of SS.",
author = "Takayuki Sumida and Naoto Azuma and Masafumi Moriyama and Hiroyuki Takahashi and Hiromitsu Asashima and Fumika Honda and Saori Abe and Yuko Ono and Tomoya Hirota and Shintaro Hirata and Yoshiya Tanaka and Toshimasa Shimizu and Hideki Nakamura and Atsushi Kawakami and Hajime Sano and Yoko Ogawa and Kazuo Tsubota and Koufuchi Ryo and Ichiro Saito and Akihiko Tanaka and Seiji Nakamura and Etsuko Takamura and Masao Tanaka and Katsuya Suzuki and Tsutomu Takeuchi and Noriyuki Yamakawa and Tsuneyo Mimori and Akiko Ohta and Susumu Nishiyama and Toshio Yoshihara and Yasunori Suzuki and Mitsuhiro Kawano and Minako Tomiita and Hiroto Tsuboi",
year = "2018",
month = "5",
day = "4",
doi = "10.1080/14397595.2018.1438093",
language = "English",
volume = "28",
pages = "383--408",
journal = "Modern Rheumatology",
issn = "1439-7595",
publisher = "Springer Japan",
number = "3",

}

TY - JOUR

T1 - Clinical practice guideline for Sjögren’s syndrome 2017

AU - Sumida, Takayuki

AU - Azuma, Naoto

AU - Moriyama, Masafumi

AU - Takahashi, Hiroyuki

AU - Asashima, Hiromitsu

AU - Honda, Fumika

AU - Abe, Saori

AU - Ono, Yuko

AU - Hirota, Tomoya

AU - Hirata, Shintaro

AU - Tanaka, Yoshiya

AU - Shimizu, Toshimasa

AU - Nakamura, Hideki

AU - Kawakami, Atsushi

AU - Sano, Hajime

AU - Ogawa, Yoko

AU - Tsubota, Kazuo

AU - Ryo, Koufuchi

AU - Saito, Ichiro

AU - Tanaka, Akihiko

AU - Nakamura, Seiji

AU - Takamura, Etsuko

AU - Tanaka, Masao

AU - Suzuki, Katsuya

AU - Takeuchi, Tsutomu

AU - Yamakawa, Noriyuki

AU - Mimori, Tsuneyo

AU - Ohta, Akiko

AU - Nishiyama, Susumu

AU - Yoshihara, Toshio

AU - Suzuki, Yasunori

AU - Kawano, Mitsuhiro

AU - Tomiita, Minako

AU - Tsuboi, Hiroto

PY - 2018/5/4

Y1 - 2018/5/4

N2 - Objectives: The objective of this study is to develop clinical practice guideline (CPG) for Sjögren’s syndrome (SS) based on recently available clinical and therapeutic evidences. Methods: The CPG committee for SS was organized by the Research Team for Autoimmune Diseases, Research Program for Intractable Disease of the Ministry of Health, Labor and Welfare (MHLW), Japan. The committee completed a systematic review of evidences for several clinical questions and developed CPG for SS 2017 according to the procedure proposed by the Medical Information Network Distribution Service (Minds). The recommendations and their strength were checked by the modified Delphi method. The CPG for SS 2017 has been officially approved by both Japan College of Rheumatology and the Japanese Society for SS. Results: The CPG committee set 38 clinical questions for clinical symptoms, signs, treatment, and management of SS in pediatric, adult and pregnant patients, using the PICO (P: patients, problem, population, I: interventions, C: comparisons, controls, comparators, O: outcomes) format. A summary of evidence, development of recommendation, recommendation, and strength for these 38 clinical questions are presented in the CPG. Conclusion: The CPG for SS 2017 should contribute to improvement and standardization of diagnosis and treatment of SS.

AB - Objectives: The objective of this study is to develop clinical practice guideline (CPG) for Sjögren’s syndrome (SS) based on recently available clinical and therapeutic evidences. Methods: The CPG committee for SS was organized by the Research Team for Autoimmune Diseases, Research Program for Intractable Disease of the Ministry of Health, Labor and Welfare (MHLW), Japan. The committee completed a systematic review of evidences for several clinical questions and developed CPG for SS 2017 according to the procedure proposed by the Medical Information Network Distribution Service (Minds). The recommendations and their strength were checked by the modified Delphi method. The CPG for SS 2017 has been officially approved by both Japan College of Rheumatology and the Japanese Society for SS. Results: The CPG committee set 38 clinical questions for clinical symptoms, signs, treatment, and management of SS in pediatric, adult and pregnant patients, using the PICO (P: patients, problem, population, I: interventions, C: comparisons, controls, comparators, O: outcomes) format. A summary of evidence, development of recommendation, recommendation, and strength for these 38 clinical questions are presented in the CPG. Conclusion: The CPG for SS 2017 should contribute to improvement and standardization of diagnosis and treatment of SS.

UR - http://www.scopus.com/inward/record.url?scp=85043701298&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043701298&partnerID=8YFLogxK

U2 - 10.1080/14397595.2018.1438093

DO - 10.1080/14397595.2018.1438093

M3 - Review article

C2 - 29409370

AN - SCOPUS:85043701298

VL - 28

SP - 383

EP - 408

JO - Modern Rheumatology

JF - Modern Rheumatology

SN - 1439-7595

IS - 3

ER -